Oct 13, 2026 07:30PM
Oct 13, 2026 07:30PM
Sep 22, 2026 08:02AM
Sep 22, 2026 08:00AM
Sep 10, 2026 08:00AM
Aug 24, 2026 08:03AM
Aug 24, 2026 08:00AM Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan
Aug 17, 2026 08:00AM
Aug 17, 2026 08:00AM
Aug 11, 2026 08:00AM
Aug 11, 2026 08:00AM
Aug 4, 2026 04:01PM
Aug 4, 2026 07:01AM
Aug 4, 2026 06:55AM Rhythm Pharmaceuticals RM-718 shows BMI reduction in Phase 2 trial
Aug 4, 2026 06:55AM
Jul 21, 2026 08:00AM
Jul 8, 2026 05:07PM
Jul 8, 2026 05:07PM
Jul 1, 2026 12:00PM
Jun 15, 2026 04:01PM
Jun 15, 2026 04:01PM Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026
Jun 15, 2026 09:31AM
Jun 13, 2026 08:01AM
Jun 13, 2026 08:01AM
Jun 12, 2026 04:01PM
Jun 12, 2026 04:01PM
Jun 3, 2026 04:43AM
May 29, 2026 08:00AM Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026
May 28, 2026 08:00AM
May 26, 2026 08:00AM
May 12, 2026 08:00AM
May 6, 2026 08:00AM
May 5, 2026 07:00AM
May 4, 2026 08:00AM
May 1, 2026 06:55AM Rhythm Pharmaceuticals gets EU approval for obesity drug IMCIVREE
May 1, 2026 06:55AM
Apr 19, 2026 10:00AM
Apr 9, 2026 08:00AM
Apr 3, 2026 09:00AM
Apr 3, 2026 09:00AM
Mar 26, 2026 02:50PM
Mar 26, 2026 09:02AM Rhythm Pharmaceuticals gets European panel backing for obesity drug
Mar 26, 2026 09:01AM
Mar 23, 2026 06:45AM
Mar 19, 2026 06:30PM
Mar 19, 2026 06:30PM
Mar 17, 2026 08:13AM
Mar 16, 2026 04:01PM
Mar 16, 2026 04:01PM Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
Mar 2, 2026 06:43AM

334,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All